Helius Medical Technologies, Inc. Announces Positive Preliminary Results of the PoNSTEP Study
Helius Medical Technologies, Inc. - Class A (HSDT)
NASDAQ:AMEX Investor Relations:
heliusmedical.com/index.php/investor-relations/overview
Company Research
Source: GlobeNewswire
-- Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in DGI scores from Phase 1 to end of treatment at week 14 -- -- Confirms the therapeutic benefits of PoNS Therapy for gait deficit improvement in people with MS -- NEWTOWN, Pa., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced positive preliminary results from its Therapeutic Experience Program open-label observational study (PoNSTEP) which evaluates the impact of subjects’ adherence to the Portable Neuromodulation Stimulator (PoNS®) Therapy program that treat gait deficit due to multiple sclerosis (“MS”). The study treatment phase is complete, and the ongoing post-treatment follow-up phase will be completed by the end of the year, with full results expected to be rele
Show less
Read more
Impact Snapshot
Event Time:
HSDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HSDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HSDT alerts
High impacting Helius Medical Technologies, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
HSDT
News
- Helius Medical Technologies, Inc. Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS®) DeviceGlobeNewswire
- Helius Medical Technologies, Inc. Announces Exploration of Strategic AlternativesGlobeNewswire
- Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity ConferenceGlobeNewswire
- Helius Medical Technologies, Inc. (NASDAQ: HSDT) had its "hold" rating re-affirmed by analysts at Maxim Group.MarketBeat
- Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece [Financial Post (Toronto, Ontario, Canada)]Financial Post
HSDT
Earnings
- 3/28/24 - Beat
HSDT
Sec Filings
- 11/18/24 - Form 8-K
- 11/12/24 - Form 10-Q
- 11/8/24 - Form SC
- HSDT's page on the SEC website